SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis

IntroductionSGLT2 inhibitors (SGLT2Is) have demonstrated cardioprotective and nephroprotective effects in patients with and without diabetes. Recent studies suggest that SGLT2Is may reduce the risk of contrast-induced nephropathy (CIN) in patients with diabetes undergoing coronary arteriography (CAG...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Edinson Dante Meregildo-Rodriguez, Martha Genara Asmat-Rubio, Gustavo Adolfo Vásquez-Tirado
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-12-01
Serija:	Frontiers in Endocrinology
Teme:	sodium-glucose transporter 2 inhibitors SGLT2 inhibitors acute kidney injury contrast-induced nephropathy systematic review meta-analysis
Online dostop:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1307715/full
Oznake:	Označite Brez oznak, prvi označite!